Stemtology

We are building a synthetic alternative to cell therapies—a tunable, cell-free system that mimics regenerative signaling with precision across indications. Our first candidate targets Osteoarthritis.

DUST Identity

At DUST Identity, we believe that authentic products tell powerful stories and build beloved brands. Our customers come to us for advanced identity tools to protect and connect the most valuable products and physical objects from battlefields to playing fields and everything in between.

Voyant Photonics

Voyant Photonics, Inc. creates LIDAR-on-a-chip solutions for 3D sensing, providing competitive performance at disruptive price, size, weight and power. Voyant uses patented nano-optic approaches to provide a range of imaging sensors for a variety of applications including autonomous vehicles, drones, robotics and factory automation. Voyant Photonics is based in New York City.

Nanowear

Nanowear is an AI-based remote diagnostics platform built on cloth-based nanotechnology with applications in the cardiac, neurological, industrial safety / government and sports medicine / performance diagnostics monitoring markets. The company’s proprietary advanced materials and AI enabled continuous and time synchronous electrophysiological, hemodynamic, acoustic, metabolic and activity monitoring that empowers medical professionals with scored, clinical-grade diagnostic data through a cost effective and gender-neutral, size adjustable undergarment - SimpleSense. Nanowear’s core focus on innovation and next-gen technologies will continue to propel the company towards exploring unique and groundbreaking applications for its nanosensors. Headquartered in New York, NY, the company’s research and development centers are located in Berkeley, CA and University Park, PA, with advanced materials production facility in Nashville, TN

Universal Display Corporation

Universal Display Corporation (Nasdaq: OLED) is lighting up the OLED revolution with its proprietary OLED technologies and proprietary phosphorescent materials. The Company is a world-class IP innovator, technology developer, patent licensor and materials supplier for the rapidly growing OLED markets. We are a leader in developing and delivering state-of-the-art, organic light emitting diode (OLED) technologies, materials and services to the display and lighting industries. Founded in 1994, the Company currently owns or has exclusive, co-exclusive or sole license rights with respect to more than 6,000 issued and pending patents worldwide. Universal Display licenses its proprietary technologies, including its breakthrough high-efficiency UniversalPHOLED® phosphorescent OLED technology, that can enable the development of low power and eco-friendly displays and lighting. The Company also develops and offers high-quality, state-of-the-art UniversalPHOLED materials that are recognized as key ingredients in the fabrication of OLEDs with peak performance. In addition, Universal Display delivers innovative and customized solutions to its clients and partners through technology transfer, collaborative technology development and on-site training. Headquartered in Ewing, New Jersey, with international offices in China, Hong Kong, Ireland, Japan, South Korea, and Taiwan, and wholly-owned subsidiary Adesis, Inc. based in New Castle, Delaware, Universal Display works and partners with a network of world-class organizations. To learn more about Universal Display Corporation, please visit https://oled.com.

Newlab

Newlab advances technologies that support the health of our planet. We act as a facilitator, connector, and translator for our community of experts and innovators, helping to build, test, and scale world-changing ideas through investment, venture building, and structured collaboration with industry and government partners. Inspired by its rich history, we envisioned a way to return 
the building to relevance by championing entrepreneurship, innovation, and frontier technologies that transform infrastructure and build a more resilient, sustainable world. We are now home to over 155 companies, solving the world’s biggest challenges with leaders and experts across industries and cities

Oxford Nanopore Technologies

Our goal is to enable the analysis of anything, anywhere, by anyone. We have developed the world’s first and only nanopore DNA and RNA sequencing platform. It’s a new generation of sequencing technology — the only one to offer: scalability to portable or ultra-high throughput formats, real-time data delivery, and the ability to elucidate rich biological data. We are aiming to disrupt the way that biological analyses are currently performed, and open up new applications that have a profound, positive impact on society. Our devices offer real-time analysis, for rapid insights, in fully scalable formats — from pocket to population scale — and the technology is being used in more than 100 countries worldwide. Founded in 2005 as a spin-out from the University of Oxford, the company now employs more than 600 people from multiple disciplines including nanopore science, molecular biology and applications, informatics, engineering, electronics, manufacturing and commercialisation. The management team, led by CEO Dr Gordon Sanghera, has a track record of delivering disruptive technologies to the market.